PubRank

Angel Porgador

Author PubWeight™ 70.68‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 2006 6.54
2 Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat Immunol 2006 5.00
3 Cell type-specific DNA methylation patterns in the human breast. Proc Natl Acad Sci U S A 2008 2.99
4 Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat Immunol 2005 2.55
5 The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46. Blood 2003 2.06
6 Retracted Novel APC-like properties of human NK cells directly regulate T cell activation. J Clin Invest 2004 1.58
7 The activating receptor NKp46 is essential for the development of type 1 diabetes. Nat Immunol 2009 1.54
8 Harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapy. PLoS One 2008 1.47
9 Membrane-associated heparan sulfate proteoglycans are involved in the recognition of cellular targets by NKp30 and NKp46. J Immunol 2004 1.43
10 Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2. Cancer Res 2011 1.41
11 Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium. J Immunol 2005 1.39
12 Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural cytotoxicity receptor NKp44. J Immunol 2011 1.37
13 Vimentin expressed on Mycobacterium tuberculosis-infected human monocytes is involved in binding to the NKp46 receptor. J Immunol 2006 1.34
14 Natural cytotoxicity receptors NKp30, NKp44 and NKp46 bind to different heparan sulfate/heparin sequences. J Proteome Res 2009 1.27
15 NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells. J Immunol 2009 1.27
16 The NKp46 receptor contributes to NK cell lysis of mononuclear phagocytes infected with an intracellular bacterium. J Immunol 2002 1.17
17 RORγt⁺ innate lymphoid cells acquire a proinflammatory program upon engagement of the activating receptor NKp44. Immunity 2013 1.14
18 Characterization of the recognition of tumor cells by the natural cytotoxicity receptor, NKp44. Biochemistry 2007 1.12
19 Activating NK cell receptor ligands are differentially expressed during progression to cervical cancer. Int J Cancer 2008 1.12
20 Altered glycosylation of recombinant NKp30 hampers binding to heparan sulfate: a lesson for the use of recombinant immunoreceptors as an immunological tool. Glycobiology 2007 1.12
21 Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection. BMC Infect Dis 2009 1.11
22 H5-type influenza virus hemagglutinin is functionally recognized by the natural killer-activating receptor NKp44. J Virol 2007 1.08
23 Characterization of the heparin/heparan sulfate binding site of the natural cytotoxicity receptor NKp46. Biochemistry 2005 1.03
24 Killing of avian and Swine influenza virus by natural killer cells. J Virol 2010 1.03
25 Recognition and killing of human and murine pancreatic beta cells by the NK receptor NKp46. J Immunol 2011 1.01
26 The mechanisms controlling NK cell autoreactivity in TAP2-deficient patients. Blood 2003 1.00
27 Flamingo cadherin: a putative host receptor for Streptococcus pneumoniae. J Infect Dis 2007 0.98
28 Identification of Salmonella typhimurium genes responsible for interference with peptide presentation on MHC class I molecules: Deltayej Salmonella mutants induce superior CD8+ T-cell responses. Cell Microbiol 2004 0.96
29 Sialylation of 3-methylcholanthrene-induced fibrosarcoma determines antitumor immune responses during immunoediting. J Immunol 2010 0.96
30 Expression of ligands to NKp46 in benign and malignant melanocytes. J Invest Dermatol 2007 0.93
31 Dengue virus replicon expressing the nonstructural proteins suffices to enhance membrane expression of HLA class I and inhibit lysis by human NK cells. J Virol 2008 0.93
32 Human NK cell recognition of target cells in the prism of natural cytotoxicity receptors and their ligands. J Immunotoxicol 2012 0.92
33 The natural cytotoxicity receptor 1 contribution to early clearance of Streptococcus pneumoniae and to natural killer-macrophage cross talk. PLoS One 2011 0.92
34 NKp46 O-glycan sequences that are involved in the interaction with hemagglutinin type 1 of influenza virus. J Virol 2010 0.91
35 Serum apolipoproteins C-I and C-III are reduced in stomach cancer patients: results from MALDI-based peptidome and immuno-based clinical assays. PLoS One 2011 0.91
36 NADH oxidase functions as an adhesin in Streptococcus pneumoniae and elicits a protective immune response in mice. PLoS One 2013 0.87
37 T7 phage display of Ep15 peptide for the detection of WNV IgG. J Virol Methods 2007 0.86
38 Streptococcus pneumoniae surface-exposed glutamyl tRNA synthetase, a putative adhesin, is able to induce a partially protective immune response in mice. J Infect Dis 2007 0.82
39 Self HSP60 peptide serves as an immunogenic carrier for a CTL epitope against persistence of murine cytomegalovirus in the salivary gland. Vaccine 2005 0.82
40 Non-replicating mucosal and systemic vaccines: quantitative and qualitative differences in the Ag-specific CD8(+) T cell population in different tissues. Vaccine 2004 0.81
41 Tumor vaccination by Salmonella typhimurium after transformation with a eukaryotic expression vector in mice: impact of a Salmonella typhimurium gene interfering with MHC class I presentation. J Immunother 2005 0.81
42 Host-derived interleukin-1alpha is important in determining the immunogenicity of 3-methylcholantrene tumor cells. J Immunol 2009 0.80
43 Reliable determination of transposon insertion site in prokaryotes by direct sequencing. J Microbiol Methods 2003 0.80
44 Regulation of natural cytotoxicity receptors by heparan sulfate proteoglycans in -cis: A lesson from NKp44. Eur J Immunol 2015 0.79
45 Lipoprotein interactions with chromatic membranes as a novel marker for oxidative stress-related diseases. Biochim Biophys Acta 2009 0.79
46 A novel mechanism for cancer cells to evade immune attack by NK cells: The interaction between NKp44 and proliferating cell nuclear antigen. Oncoimmunology 2012 0.79
47 Dimerization of NKp46 receptor is essential for NKp46-mediated lysis: characterization of the dimerization site by epitope mapping. J Immunol 2012 0.78
48 Upregulation of MHC class I expression following dengue virus infection: the mechanism at the promoter level. Expert Rev Anti Infect Ther 2012 0.78
49 Chimeric vaccine composed of viral peptide and mammalian heat-shock protein 60 peptide protects against West Nile virus challenge. Immunology 2010 0.78
50 CD100 on NK cells enhance IFNgamma secretion and killing of target cells expressing CD72. PLoS One 2007 0.77
51 Rapid chromatic detection of bacteria by use of a new biomimetic polymer sensor. Appl Environ Microbiol 2006 0.77
52 Glycans in sera of amyotrophic lateral sclerosis patients and their role in killing neuronal cells. PLoS One 2012 0.76
53 α1-Antitrypsin modifies general NK cell interactions with dendritic cells and specific interactions with islet β-cells in favor of protection from autoimmune diabetes. Immunology 2014 0.76
54 Generating NK cell receptor-Fc chimera proteins from 293T cells and considerations of appropriate glycosylation. Methods Mol Biol 2010 0.76
55 Dual fluorescent labelling of the human malaria parasite Plasmodium falciparum for the analysis of the ABC type transporter pfmdr2. Malar J 2012 0.75
56 Correction: harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapy. PLoS One 2015 0.75
57 A novel "reactomics" approach for cancer diagnostics. Sensors (Basel) 2012 0.75
58 Colorimetric polymer assay for the diagnosis of plasma lipids atherogenic quality in hypercholesterolemic patients. Mol Diagn Ther 2015 0.75